Clinical Trials

NCT04250545 | ACTIVE_NOT_RECRUITING | PHASE1
22 participants

Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2020-10-26
Completion:
2025-11-21
Conditions
  • Leptomeningeal Neoplasm
  • Metastatic Lung Non-Small Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Brain
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
NCT03887988 | ACTIVE_NOT_RECRUITING
300 participants

Orbital Fractures Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-26
Start Date:
2019-11-01
Completion:
2026-12-31
Conditions
  • Orbital Fractures
  • Blow Out Fracture of Orbit
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT03820817 | COMPLETED | PHASE1
50 participants

Rifaximin in Patients With Monoclonal Gammopathy

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-05-15
Completion:
2025-11-30
Conditions
  • IgA Monoclonal Gammopathy
  • IgG Monoclonal Gammopathy
  • IgM Monoclonal Gammopathy
  • Light Chain Deposition Disease
  • Monoclonal Gammopathy
  • Smoldering Waldenstrom Macroglobulinemia
  • Waldenstrom Macroglobulinemia
  • Gammopathy, Monoclonal
  • Gammopathy Igg
Interventions
  • DRUG
No Results Yet
NCT03598998 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
13 participants

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-02-04
Completion:
2023-05-03
Conditions
  • Anaplastic Large Cell Lymphoma
  • Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
  • Recurrent Anaplastic Large Cell Lymphoma
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • Recurrent Enteropathy-Associated T-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Hepatosplenic T-Cell Lymphoma
  • Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma
  • Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  • Recurrent Mycosis Fungoides
  • Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Refractory Anaplastic Large Cell Lymphoma
  • Refractory Angioimmunoblastic T-Cell Lymphoma
  • Refractory Enteropathy-Associated T-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Hepatosplenic T-Cell Lymphoma
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Refractory Mycosis Fungoides
  • Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Subcutaneous Panniculitis-Like T-Cell Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
NCT03570827 | COMPLETED | PHASE2
53 participants

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2018-05-14
Completion:
2025-05-15
Conditions
  • Prostate Adenocarcinoma
  • Stage IIB Prostate Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage IIIA Prostate Cancer AJCC v8
  • Stage IIIB Prostate Cancer AJCC v8
  • Stage IIIC Prostate Cancer AJCC v8
Interventions
  • RADIATION
  • OTHER
  • DRUG
NCT03434730 | COMPLETED | PHASE2
46 participants

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2018-02-07
Completion:
2025-04-18
Conditions
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Leukemia
  • Myelodysplastic Syndromes
  • Myelodysplastic-Myeloproliferative Diseases
  • Myeloproliferative Disorder
  • Non Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Leukemia
Interventions
  • RADIATION
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page